Hyperchloremia is not associated with AKI or death in septic shock patients: results of a post hoc analysis of the "HYPER2S" trial.
Morgane CommereucCamille NevoretPeter RadermacherSandrine KatsahianPierre AsfarFrédérique Schortgennull nullPublished in: Annals of intensive care (2019)
Despite more frequent metabolic acidosis, hyperchloremia was not associated with an increased risk for AKI or mortality. Trial registration ClinicalTrials.gov, identifier: NCT01722422, registered 2 November 2012.
Keyphrases
- septic shock
- acute kidney injury
- end stage renal disease
- study protocol
- clinical trial
- phase iii
- ejection fraction
- newly diagnosed
- phase ii
- chronic kidney disease
- prognostic factors
- cardiovascular events
- peritoneal dialysis
- randomized controlled trial
- risk factors
- cardiovascular disease
- coronary artery disease
- placebo controlled
- cone beam